BridgeMD
New treatment option for Hip Dysplasia
Official title Can PLIA Reduce Early Post-operative Pain After PAO Surgery?
ClinicalTrials.gov ID: NCT06519955
What this study is testing
What is Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline)?
Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline) is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for hip dysplasia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to compare different peri-incisional local infiltrative anesthesia (PLIA) methods in patients ages 13 to 50 undergoing a periacetabular osteotomy (PAO). The main questions to answer here are: 1.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 50. Healthy volunteers may be eligible.
You may be able to join if
- Adolescent or young adult diagnosed with hip dysplasia indicated for PAO at University of Iowa Hospital and Clinics.
You likely can't join if
- Unable to provide informed consent.
- Pregnant or breast-feeding individuals
- Prisoner or ward of the state
- Allergy or medical contradiction to any of the study medications
- Patients undergoing femoral osteotomy or surgical hip dislocation with PAO will be excluded
The study team makes the final eligibility decision.
Where it's taking place
- Iowa City, Iowa, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Iowa City, Iowa, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.